BR112015029973A2 - método para produção de toxina botulínica - Google Patents

método para produção de toxina botulínica

Info

Publication number
BR112015029973A2
BR112015029973A2 BR112015029973A BR112015029973A BR112015029973A2 BR 112015029973 A2 BR112015029973 A2 BR 112015029973A2 BR 112015029973 A BR112015029973 A BR 112015029973A BR 112015029973 A BR112015029973 A BR 112015029973A BR 112015029973 A2 BR112015029973 A2 BR 112015029973A2
Authority
BR
Brazil
Prior art keywords
botulinum toxin
precipitate
toxin
botulinum
treatment
Prior art date
Application number
BR112015029973A
Other languages
English (en)
Other versions
BR112015029973B1 (pt
Inventor
Sei Kim Chung
Young Song Kwan
Min Min Kyoung
Duk An Yeong
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49987856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015029973(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of BR112015029973A2 publication Critical patent/BR112015029973A2/pt
Publication of BR112015029973B1 publication Critical patent/BR112015029973B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

resumo mƒtodo para produ‚ìo de toxina botulênica, mais particularmente, a um mžtodo de prepara‹o de toxina botul’nica, compreendendo as etapas de: (a) tratar uma cultura de uma cepa produtora de toxina botul’nica com ‡cido para precipitar uma toxina botul’nica; (b) adicionar tamp‹o ˆ toxina botul’nica precipitada, seguido pelo tratamento com um inibidor de protease e nuclease, assim extraindo a toxina botul’nica; (c) tratar a toxina botul’nica extra’da com ‡cido para precipitar a toxina botul’nica e dissolver o precipitado em tamp‹o; e (d) purificar a toxina botul’nica por cromatografia de troca ani™nica. o uso do mžtodo da toxina da inven‹o torna poss’vel produzir uma toxina botul’nica de alta pureza por um processo simples, sugerindo que o mžtodo ž muito econ™mico e eficiente. a toxina botul’nica produzida pelo mžtodo da inven‹o tem alta pureza comparado ˆs toxinas botul’nicas produzidas por mžtodos convencionais e, portanto, tem uma capacidade aumentada para agir em uma ‡rea local. portanto, a circula‹o sistem‡tica da toxina botul’nica, que pode resultar em efeitos colaterais, ž reduzida para aumentar a segurana. de acordo, a toxina botul’nica da inven‹o pode ser utilizada para v‡rios prop—sitos, incluindo tratamento de distœrbios neuromusculares, remo‹o de rugas e tratamento de hemiplegia esp‡stica e paralisia cerebral. 1/1
BR112015029973-3A 2013-08-02 2014-05-07 Método para produção de toxina botulínica BR112015029973B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020130092024A KR101339349B1 (ko) 2013-08-02 2013-08-02 보툴리눔 독소의 제조방법
KR10-2013-0092024 2013-08-02
PCT/KR2014/004003 WO2015016462A1 (en) 2013-08-02 2014-05-07 Method for production of botulinum toxin

Publications (2)

Publication Number Publication Date
BR112015029973A2 true BR112015029973A2 (pt) 2017-07-25
BR112015029973B1 BR112015029973B1 (pt) 2023-01-17

Family

ID=49987856

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015029973-3A BR112015029973B1 (pt) 2013-08-02 2014-05-07 Método para produção de toxina botulínica

Country Status (26)

Country Link
US (1) US9512418B2 (pt)
EP (1) EP2920199B1 (pt)
JP (2) JP6307150B2 (pt)
KR (1) KR101339349B1 (pt)
CN (1) CN105392795B (pt)
AR (1) AR096541A1 (pt)
AU (1) AU2014297167B2 (pt)
BR (1) BR112015029973B1 (pt)
CA (1) CA2912553C (pt)
CY (1) CY1120410T1 (pt)
DK (1) DK2920199T3 (pt)
ES (1) ES2665288T3 (pt)
HK (1) HK1215715A1 (pt)
HR (1) HRP20180679T1 (pt)
HU (1) HUE036840T2 (pt)
LT (1) LT2920199T (pt)
MX (1) MX362821B (pt)
NO (1) NO2920199T3 (pt)
PH (1) PH12015501855B1 (pt)
PL (1) PL2920199T3 (pt)
PT (1) PT2920199T (pt)
RU (1) RU2627159C2 (pt)
SA (1) SA515370208B1 (pt)
SG (1) SG11201509486VA (pt)
SI (1) SI2920199T1 (pt)
WO (1) WO2015016462A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법
KR101723167B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101729251B1 (ko) 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101853463B1 (ko) * 2015-09-09 2018-06-20 휴젤(주) 보툴리눔 독소의 정제 방법
KR101775682B1 (ko) * 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
UA127310C2 (uk) * 2016-05-16 2023-07-19 Презідент Енд Феллоуз Оф Гарвард Колледж Спосіб очищення і активації ботулінічного нейротоксину
KR102463881B1 (ko) 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
KR101744900B1 (ko) 2017-01-20 2017-06-08 주식회사 대웅 보툴리눔 독소를 포함하는 안정한 액상 조성물
CN109646673A (zh) * 2017-10-12 2019-04-19 秀杰股份公司 肉毒杆菌毒素的微结构制剂技术
EP3901163A4 (en) 2018-12-21 2022-10-05 The Research Foundation for Microbial Diseases of Osaka University PROCESS FOR THE PRODUCTION OF BOTULINUM TOXIN
KR102485146B1 (ko) * 2019-04-15 2023-01-06 (주)제테마 보툴리눔 독소의 제조방법
KR102447441B1 (ko) * 2019-04-15 2022-09-27 (주)제테마 보툴리눔 독소의 정제방법
WO2023186016A1 (zh) * 2022-04-01 2023-10-05 重庆誉颜制药有限公司 一种肉毒毒素蛋白组合物、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030060150A (ko) * 2002-01-07 2003-07-16 (주)메디톡스 클로스트리디움 보툴리눔 ａ형 독소를 정제하는 방법
RU2206337C1 (ru) * 2002-10-29 2003-06-20 Общество с ограниченной ответственностью "Токсины и сопутствующие продукты" Лекарственный препарат для лечения мышечных дистоний и способ его получения
US7452697B2 (en) * 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
KR100852822B1 (ko) * 2004-07-26 2008-08-18 메르츠 파마 게엠베하 운트 코. 카가아 보툴리눔 신경독소를 포함하는 치료 조성물
ES2509872T3 (es) 2005-03-03 2014-10-20 Allergan, Inc. Procedimientos para obtener una toxina clostrídica
KR101025617B1 (ko) * 2008-02-25 2011-03-30 메덱스젠 주식회사 클로스트리디움 보툴리눔으로부터 보툴리눔 독소를정제하는 방법
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
ES2688065T3 (es) * 2009-10-21 2018-10-30 Revance Therapeutics, Inc. Métodos y sistemas para purificar la neurotoxina botulínica no complejada
KR101434558B1 (ko) * 2011-07-21 2014-08-27 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여 클로스트리디움 보툴리눔 독소를 생산하는 방법
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
DK2920199T3 (en) 2018-05-28
PT2920199T (pt) 2018-05-30
EP2920199A4 (en) 2016-10-05
KR101339349B1 (ko) 2013-12-09
WO2015016462A1 (en) 2015-02-05
US20150337281A1 (en) 2015-11-26
HRP20180679T1 (hr) 2018-06-01
SG11201509486VA (en) 2015-12-30
MX362821B (es) 2019-02-18
JP2016521968A (ja) 2016-07-28
US9512418B2 (en) 2016-12-06
BR112015029973B1 (pt) 2023-01-17
JP2017141237A (ja) 2017-08-17
CY1120410T1 (el) 2019-07-10
JP6307150B2 (ja) 2018-04-04
CN105392795B (zh) 2019-11-22
NO2920199T3 (pt) 2018-08-04
RU2015151186A (ru) 2017-06-01
AR096541A1 (es) 2016-01-13
HUE036840T2 (hu) 2018-08-28
RU2627159C2 (ru) 2017-08-03
PL2920199T3 (pl) 2018-08-31
SI2920199T1 (en) 2018-06-29
PH12015501855A1 (en) 2015-12-07
HK1215715A1 (zh) 2016-09-09
ES2665288T3 (es) 2018-04-25
CA2912553C (en) 2018-01-02
PH12015501855B1 (en) 2015-12-07
SA515370208B1 (ar) 2017-07-08
EP2920199B1 (en) 2018-03-07
EP2920199A1 (en) 2015-09-23
AU2014297167A1 (en) 2015-12-10
LT2920199T (lt) 2018-04-10
CA2912553A1 (en) 2015-02-05
CN105392795A (zh) 2016-03-09
AU2014297167B2 (en) 2016-11-17
MX2015016481A (es) 2016-06-10

Similar Documents

Publication Publication Date Title
BR112015029973A2 (pt) método para produção de toxina botulínica
PH12020550671A1 (en) Process for the purification of a sialic acid from a fermentation broth
BR112014031359A2 (pt) ligas de alumínio aprimoradas e métodos para produzir as mesmas
CO2022010432A2 (es) Método basado en tecnología leaper para el tratamiento de mucopolisacaridosis ih y composición
BR112018075516A2 (pt) purificação de anticorpos multiespecíficos
BR112014027978A2 (pt) carbono ativado biogênico e métodos de produção e utilização do mesmo
BR112012028507A2 (pt) processo para recuperação de etanol com extrações laterais para regular as concentrações de c3 + alcoóis
BR112016001837A2 (pt) processo para recuperar e purificar poli-hidroxialcanoatos de uma cultura celular
BR112016003528A8 (pt) modulação de receptor imuno para tratamento de câncer e infecções virais
BRPI0511319A (pt) método para a formação de partìculas de óxido de ferro de pequeno tamanho, partìculas de óxido de ferro, preparação compreendendo as mesmas, métodos para a produção da referida preparação, para a formação de pigmento e de catalisador e produção industrial
EA201991790A1 (ru) Терапевтические препараты апремиласта для местного применения
MY169333A (en) Composition for preventing or treating hangover
BR112015010182A2 (pt) processo para alisamento e tingimento de cabelo
BR112015012689A2 (pt) método para purificar uma mistura aquosa e sistema para purificar uma mistura aquosa
BR112014018044A8 (pt) Processo para preparação de sílicas precipitadas
BR112015001655A2 (pt) método para purificar pelo menos uma saponina em uma solução, componente de produto de saponina qs-21 purificada, e, composição imunogênica
EA201890853A1 (ru) Способ обработки призабойной зоны пласта
BR112013024257A2 (pt) método para reduzir ou prevenir a incrustação em um processo de produção de ácido fosfórico em processo a úmido
BR112019000521A2 (pt) forma de cristal de intermediário de dapagliflozina e método de preparação do mesmo
BR112015013542A2 (pt) processo de produção de acrilato de alquila
BR112015026608A2 (pt) processo para produção de olefina
BR112018000119A2 (pt) processo para tratar leite
BR112014018051A8 (pt) Processo para preparação de sílicas precipitadas
BR112013022304A2 (pt) processo para a recuperação contínua de ácido (met) acrílico e aparelho para o processo
BR112018011564A2 (pt) solução de dióxido de titânio neutra, fotoativa concentrada

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/05/2014, OBSERVADAS AS CONDICOES LEGAIS